Position in EXEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$638,501
+$340,802 QoQ
Shares Held
11,735
+69.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#396
of 754 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROTHSCHILD INVESTMENT LLC holds $12,549,080 across 228 Biotechnology names. EXEL ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,038 | $2,005,795 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
6,237 | $1,502,929 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
12,195 | $1,060,355 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
15,577 | $891,315 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,761 | $831,143 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
3,970 | $743,501 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,168 | $728,294 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
11,735 | $638,501 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $638,501 | 11,735 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $297,699 | 6,941 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $369,355 | 8,427 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $199,561 | 4,832 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $220 | 5 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||